Multiple Sclerosis and Autoimmunity: A Veiled Relationship

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2022 May 24

PMID 35607574

Authors

Zineb Barkhane

Jalal Elmadi

Lakshmi Satish Kumar

Lakshmi Sree Pugalenthi

Mahlika Ahmad

Sanjana Reddy

Affiliations

Soon will be listed here.

Abstract

Multiple sclerosis (MS) is an autoimmune inflammatory illness that affects the central nervous system (CNS) when the body's immune system attacks its tissue. It is characterized by demyelination and varying degrees of axonal loss. This article has compiled various studies elaborating MS and other autoimmune diseases (ADs) co-occurrence. Several conditions that fall into this category, including type 1 diabetes (T1D), rheumatoid arthritis (RA), Guillain-Barre syndrome (GBS), myasthenia gravis (MG), and many others, are found in MS patients and their relatives, suggesting one or more common etiologic mechanisms, including genetic, environmental, and immunological factors, supporting the concept of a possible influence of poly-autoimmunity on MS and the rest of ADs, as well as providing a significant feature for early detection of the disease and also a potential treatment option by clinical neurologists.

Citing Articles

Advances in Multiple Sclerosis.

Rivera V Biomedicines. 2025; 13(2).

PMID: 40002680 PMC: 11852374. DOI: 10.3390/biomedicines13020266.

The Potential of Transcranial Direct Current Stimulation (tDCS) in Improving Quality of Life in Patients with Multiple Sclerosis: A Review and Discussion of Mechanisms of Action.

Chmiel J, Kurpas D, Stepien-Slodkowska M J Clin Med. 2025; 14(2).

PMID: 39860377 PMC: 11766291. DOI: 10.3390/jcm14020373.

A Hypoxia-Inflammation Cycle and Multiple Sclerosis: Mechanisms and Therapeutic Implications.

Soroush A, Dunn J Curr Treat Options Neurol. 2024; 27(1):6.

PMID: 39569339 PMC: 11573864. DOI: 10.1007/s11940-024-00816-4.

Prevalence of comorbid autoimmune diseases and antibodies in newly diagnosed multiple sclerosis patients.

Jendretzky K, Lezius L, Thiele T, Konen F, Huss A, Heitmann L Neurol Res Pract. 2024; 6(1):55.

PMID: 39533435 PMC: 11556020. DOI: 10.1186/s42466-024-00351-2.

Comprehensive analysis of the global impact and distribution of tick paralysis, a deadly neurological yet fully reversible condition.

Deng Y, Fu Y, Elsheikha H, Cao M, Zhu X, Wang J Clin Microbiol Rev. 2024; 37(4):e0007424.

PMID: 39440956 PMC: 11629633. DOI: 10.1128/cmr.00074-24.

References

Deretzi G, Kountouras J, Polyzos S, Zavos C, Giartza-Taxidou E, Gavalas E . Gastrointestinal immune system and brain dialogue implicated in neuroinflammatory and neurodegenerative diseases. Curr Mol Med. 2011; 11(8):696-707. DOI: 10.2174/156652411797536660. View

Dobson R, Ramagopalan S, Davis A, Giovannoni G . Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude. J Neurol Neurosurg Psychiatry. 2013; 84(8):909-14. DOI: 10.1136/jnnp-2012-304695. View

Uysal Tan F, Tellioglu S, Aydin G, Erdemoglu A, Keles I . Ankylosing spondylitis and multiple sclerosis in an HLA-B27 negative patient. Acta Neurol Belg. 2005; 104(4):169-72. View

Filippi M, Bar-Or A, Piehl F, Preziosa P, Solari A, Vukusic S . Multiple sclerosis. Nat Rev Dis Primers. 2018; 4(1):43. DOI: 10.1038/s41572-018-0041-4. View

Li S, Jin T, Zhang H, Yu H, Meng F, Quezada H . Circulating Th17, Th22, and Th1 cells are elevated in the Guillain-Barré syndrome and downregulated by IVIg treatments. Mediators Inflamm. 2014; 2014:740947. PMC: 4036596. DOI: 10.1155/2014/740947. View

Dorman J, Steenkiste A, Burke J, Songini M . Type 1 diabetes and multiple sclerosis: together at last. Diabetes Care. 2003; 26(11):3192-3. DOI: 10.2337/diacare.26.11.3192. View

Tao Y, Zhang X, Chopra M, Kim M, Buch K, Kong D . The role of endogenous IFN-β in the regulation of Th17 responses in patients with relapsing-remitting multiple sclerosis. J Immunol. 2014; 192(12):5610-7. DOI: 10.4049/jimmunol.1302580. View

Wojkowska D, Szpakowski P, Ksiazek-Winiarek D, Leszczynski M, Glabinski A . Interactions between neutrophils, Th17 cells, and chemokines during the initiation of experimental model of multiple sclerosis. Mediators Inflamm. 2014; 2014:590409. PMC: 3945772. DOI: 10.1155/2014/590409. View

Durelli L, Conti L, Clerico M, Boselli D, Contessa G, Ripellino P . T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta. Ann Neurol. 2009; 65(5):499-509. DOI: 10.1002/ana.21652. View

10.

Chen D, Chen Y, Chen H, Hsieh C, Lin C, Lan J . Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-α therapy. Arthritis Res Ther. 2011; 13(4):R126. PMC: 3239366. DOI: 10.1186/ar3431. View

11.

Seyfert S, Klapps P, Meisel C, Fischer T, Junghan U . Multiple sclerosis and other immunologic diseases. Acta Neurol Scand. 1990; 81(1):37-42. DOI: 10.1111/j.1600-0404.1990.tb00928.x. View

12.

Schminke B, Trautmann S, Mai B, Miosge N, Blaschke S . Interleukin 17 inhibits progenitor cells in rheumatoid arthritis cartilage. Eur J Immunol. 2015; 46(2):440-5. PMC: 5064647. DOI: 10.1002/eji.201545910. View

13.

Mechelli R, Umeton R, Policano C, Annibali V, Coarelli G, Ricigliano V . A "candidate-interactome" aggregate analysis of genome-wide association data in multiple sclerosis. PLoS One. 2013; 8(5):e63300. PMC: 3655974. DOI: 10.1371/journal.pone.0063300. View

14.

Kountouras J, Zavos C, Gavalas E, Deretzi G, Katsinelos P, Boura P . Helicobacter pylori may be a common denominator associated with systemic and multiple sclerosis. Joint Bone Spine. 2011; 78(2):222-3. DOI: 10.1016/j.jbspin.2011.01.006. View

15.

Matusevicius D, Kivisakk P, He B, Kostulas N, Ozenci V, Fredrikson S . Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult Scler. 1999; 5(2):101-4. DOI: 10.1177/135245859900500206. View

16.

Poser C, Paty D, Scheinberg L, McDonald W, Davis F, Ebers G . New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983; 13(3):227-31. DOI: 10.1002/ana.410130302. View

17.

Nejentsev S, Howson J, Walker N, Szeszko J, Field S, Stevens H . Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature. 2007; 450(7171):887-92. PMC: 2703779. DOI: 10.1038/nature06406. View

18.

Parkkonen P, Hyoty H, Ilonen J, Reijonen H, Yla-Herttuala S, Leinikki P . Antibody reactivity to an Epstein-Barr virus BERF4-encoded epitope occurring also in Asp-57 region of HLA-DQ8 beta chain. Childhood Diabetes in Finland Study Group. Clin Exp Immunol. 1994; 95(2):287-93. PMC: 1534924. DOI: 10.1111/j.1365-2249.1994.tb06525.x. View

19.

Lernmark A . Multiple sclerosis and type 1 diabetes: an unlikely alliance. Lancet. 2002; 359(9316):1450-1. DOI: 10.1016/S0140-6736(02)08464-7. View

20.

Ndongo-Thiam N, Miossec P . A cell-based bioassay for circulating bioactive IL-17: application to destruction in rheumatoid arthritis. Ann Rheum Dis. 2015; 74(8):1629-31. DOI: 10.1136/annrheumdis-2014-207110. View